NIH-funded research R01 grant

Dissolved Phase Hyperpolarized Xenon-129 MRI to spot early lung changes in young e-cigarette users

Official title: Dissolved Phase Hyperpolarized Xenon-129 MRI: a novel biomarker to quantify pulmonary pathology in young healthy e-cigarette users

Funded at Weill Medical Coll of Cornell Univ · NIH-11537587 · Data updated 2026-11-12

A new imaging technique using dissolved-phase hyperpolarized Xenon-129 MRI looks for early lung changes in young healthy people who use e-cigarettes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startMay 15, 2026
Project endApril 30, 2029
Funding year2026
Award (this year)$730,756
NIH project number7R01DA059660-03
Project IDNIH-11537587 on NIH RePORTER

Who could benefit from this research

Could help

Healthy young adults who use e-cigarettes and have normal standard lung function tests.

Less likely to help

People without e-cigarette exposure or those with established lung disease may not benefit from this imaging biomarker.

What this research studies

This project uses an advanced MRI method to quantify how e-cigarette use may disrupt lung tissue and blood vessel function in the early days of exposure. By focusing on gas exchange in specific lung compartments, it aims to reveal subtle, early pathologies that standard tests might miss. The study builds on prior pilot data showing dysregulated gas exchange in young e-cigarette users with normal traditional lung tests. Researchers will optimize and apply the 3D HXeMRI technique to detect regional changes in airway, interstitial tissues, and capillary function. The effort seeks to establish a new imaging biomarker that could signal early lung health impact from vaping before symptoms arise.

Why it matters

Potential benefit: If successful, this imaging biomarker could enable earlier detection and monitoring of vaping-related lung changes, potentially guiding prevention and intervention.

How similar studies have gone: Earlier pilot work suggests HXeMRI can detect subtle lung changes in young e-cigarette users, supporting potential for broader findings.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Shim, Yun Michael — Weill Medical Coll of Cornell Univ
  • Study coordinator: Shim, Yun Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.